glp-1 eczema Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports First Topical Therapy for Chronic

1 mg once weekly by subcutaneous injection

Make sure to include your initial BMI if youve lost weight during treatment

Because these are compounded or made separately, they are not subject to the same quality control measures as typical medications

None of the approved GLP-1 or dual-agonist products carries a dermatologic indication, and the largest relevant real-world study, a target trial emulation with matched cohorts of 169,630 each, found no significant differences for inflammatory or autoimmune skin outcomes other than psoriasis, pemphigus and bullous pemphigoid after correction for multiple testing

The prescribing information for semaglutide and tirzepatide contains no specific drug-alcohol interaction warning, though clinical caution is advised